Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis.
暂无分享,去创建一个
[1] Douglas K Owens,et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.
[2] S. Loeb,et al. Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators. , 2017, The Urologic clinics of North America.
[3] T. Wilt,et al. Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer , 2017, The New England journal of medicine.
[4] John W. Scott,et al. A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer. , 2015, European urology.
[5] T. Tammela,et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up , 2014, The Lancet.
[6] Hans Lilja,et al. It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening. , 2014, European urology.
[7] S. Eggener,et al. National trends in prostate cancer screening among older American men with limited 9‐year life expectancies: Evidence of an increased need for shared decision making , 2014, Cancer.
[8] A. Vickers,et al. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study , 2014, BMJ : British Medical Journal.
[9] Andrew J Vickers,et al. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen , 2014, BMC Medicine.
[10] Matthew R Cooperberg,et al. Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] A. Vickers,et al. Low annual caseloads of United States surgeons conducting radical prostatectomy. , 2009, The Journal of urology.
[12] D. Jolley,et al. The Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta‐Analysis , 2009, CA: a cancer journal for clinicians.
[13] Dante diTommaso,et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.